Arash Shakeri

447 total citations
17 papers, 352 citations indexed

About

Arash Shakeri is a scholar working on Physiology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Arash Shakeri has authored 17 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Pharmacology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Arash Shakeri's work include Alzheimer's disease research and treatments (8 papers), Computational Drug Discovery Methods (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Arash Shakeri is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Computational Drug Discovery Methods (7 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Arash Shakeri collaborates with scholars based in Canada, Portugal and United States. Arash Shakeri's co-authors include Praveen P. N. Rao, Tarek Mohamed, Gary Tin, Fernando Remião, Patrício Soares‐da‐Silva, Fernanda Borges, Tiago Silva, Yusheng Zhao, Chandra Mouli R. Madhuranthakam and Levin Thomas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Advanced Science.

In The Last Decade

Arash Shakeri

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arash Shakeri Canada 9 161 146 116 106 54 17 352
Francinaldo Sarges Braga Brazil 9 90 0.6× 92 0.6× 95 0.8× 93 0.9× 72 1.3× 20 347
Sandra Gunesch Germany 9 72 0.4× 216 1.5× 146 1.3× 109 1.0× 59 1.1× 11 378
Sukriti Srivastava India 6 158 1.0× 161 1.1× 166 1.4× 79 0.7× 55 1.0× 14 556
Elena Bovina Russia 5 134 0.8× 180 1.2× 93 0.8× 115 1.1× 90 1.7× 11 346
Özden Tacal Türkiye 12 75 0.5× 169 1.2× 131 1.1× 102 1.0× 33 0.6× 33 352
Akash Marathakam India 10 57 0.4× 126 0.9× 121 1.0× 61 0.6× 97 1.8× 19 381
Erika Sironi Italy 11 195 1.2× 104 0.7× 189 1.6× 40 0.4× 116 2.1× 14 443
Gurjit Singh India 14 84 0.5× 127 0.9× 123 1.1× 35 0.3× 116 2.1× 25 440
Baichen Xiong China 9 68 0.4× 233 1.6× 144 1.2× 157 1.5× 89 1.6× 13 450
Loreto Martínez‐González Spain 15 119 0.7× 187 1.3× 255 2.2× 86 0.8× 115 2.1× 29 576

Countries citing papers authored by Arash Shakeri

Since Specialization
Citations

This map shows the geographic impact of Arash Shakeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Shakeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Shakeri more than expected).

Fields of papers citing papers by Arash Shakeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Shakeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Shakeri. The network helps show where Arash Shakeri may publish in the future.

Co-authorship network of co-authors of Arash Shakeri

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Shakeri. A scholar is included among the top collaborators of Arash Shakeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Shakeri. Arash Shakeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shakeri, Arash, et al.. (2025). Novel Phenoselenazines as Amyloid-β Aggregation Inhibitors. ACS Medicinal Chemistry Letters. 16(4). 567–574. 2 indexed citations
2.
Keyvani, Fatemeh, Mohammad Soltani, Yusheng Zhao, et al.. (2024). Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic Treatment. Advanced Science. 11(41). e2309027–e2309027. 22 indexed citations
3.
Shakeri, Arash, et al.. (2024). Benzofuran and Benzo[b]thiophene‐2‐Carboxamide Derivatives as Modulators of Amyloid Beta (Aβ42) Aggregation. ChemMedChem. 19(22). e202400198–e202400198. 3 indexed citations
4.
Shakeri, Arash, et al.. (2024). N-Benzyl, N-phenethyl and N-benzyloxybenzamide derivatives inhibit amyloid-beta (Aβ42) aggregation and mitigate Aβ42-induced neurotoxicity. Medicinal Chemistry Research. 33(7). 1229–1241. 1 indexed citations
5.
6.
Rao, Praveen P. N., et al.. (2021). Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands. European Journal of Medicinal Chemistry. 225. 113753–113753. 5 indexed citations
7.
Rao, Praveen P. N., et al.. (2021). Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals. 14(1). 44–44. 11 indexed citations
8.
Madhuranthakam, Chandra Mouli R., Arash Shakeri, & Praveen P. N. Rao. (2021). Modeling the Inhibition Kinetics of Curcumin, Orange G, and Resveratrol with Amyloid-β Peptide. ACS Omega. 6(12). 8680–8686. 12 indexed citations
9.
Munisamy, Murali, Levin Thomas, Arash Shakeri, et al.. (2021). Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions.. PubMed. 11(12). 5762–5781. 30 indexed citations
10.
Rao, Praveen P. N., et al.. (2020). Drug repurposing for Alzheimer’s disease: Selective serotonin reuptake inhibitors. Alzheimer s & Dementia. 16(S9). 1 indexed citations
11.
Silva, Tiago, Tarek Mohamed, Arash Shakeri, et al.. (2019). Repurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6. European Journal of Medicinal Chemistry. 167. 146–152. 24 indexed citations
12.
Shakeri, Arash, et al.. (2018). A case of splenogonadal fusion accompanied by accessory spleen in a 4-year-old boy. Urology Annals. 10(4). 406–406. 5 indexed citations
13.
Tin, Gary, et al.. (2018). Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid. ACS Chemical Neuroscience. 10(1). 226–234. 20 indexed citations
14.
Mohamed, Tarek, Arash Shakeri, Gary Tin, & Praveen P. N. Rao. (2016). Structure–Activity Relationship Studies of Isomeric 2,4-Diaminoquinazolines on β-Amyloid Aggregation Kinetics. ACS Medicinal Chemistry Letters. 7(5). 502–507. 19 indexed citations
15.
Mohamed, Tarek, Arash Shakeri, & Praveen P. N. Rao. (2016). Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry. European Journal of Medicinal Chemistry. 113. 258–272. 156 indexed citations
16.
Shakeri, Arash & Praveen P. N. Rao. (2016). P2‐046: Evaluation of Novel Adamantane Derivatives as Potential Dual Inhibitors of Amyloid Beta and TAU Aggregation. Alzheimer s & Dementia. 12(7S_Part_13). 1 indexed citations
17.
Silva, Tiago, Tarek Mohamed, Arash Shakeri, et al.. (2016). Development of Blood–Brain Barrier Permeable Nitrocatechol-Based CatecholO-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity. Journal of Medicinal Chemistry. 59(16). 7584–7597. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francinaldo Sarges Braga Breakdown of academic impact, for papers by Sandra Gunesch Breakdown of academic impact, for papers by Sukriti Srivastava Breakdown of academic impact, for papers by Elena Bovina Breakdown of academic impact, for papers by Özden Tacal Breakdown of academic impact, for papers by Akash Marathakam Breakdown of academic impact, for papers by Erika Sironi Breakdown of academic impact, for papers by Gurjit Singh Breakdown of academic impact, for papers by Baichen Xiong Breakdown of academic impact, for papers by Loreto Martínez‐González
Rankless by CCL
2026